This is a U.S. news story, published by ABC News, that relates primarily to Drugmaker Novo Nordisk news.
For more U.S. news, you can click here:
more U.S. newsFor more Drugmaker Novo Nordisk news, you can click here:
more Drugmaker Novo Nordisk newsFor more drug discoveries news, you can click here:
more drug discoveries newsFor more news from ABC News, you can click here:
more news from ABC NewsOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
loss drug Saxenda. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest pediatric obesity specialist news, childhood obesity news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
pediatric obesity expertABC News
•
82% Informative
Liraglutide lowered body mass, slowed weight gain and improved health markers in kids ages 6 through 11 .
Drugmaker Novo Nordisk has asked U.S. regulators to expand use of the medication for kids in that age group.
If approved, the drug would be the first authorized to treat the most common type of obesity.
The drug treats the underlying physiology of obesity, which is a complex, chronic disease that can occur at any age.
Dr. Alaina Vidmar , a pediatric obesity specialist at Children's Hospital Los Angeles , said she has used liraglutide off-label to treat young kids and would welcome approval of the drug.
VR Score
90
Informative language
96
Neutral language
19
Article tone
semi-formal
Language
English
Language complexity
47
Offensive language
possibly offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
medium-lived
External references
1
Source diversity
1
Affiliate links
no affiliate links